The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten ...
Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli Lilly's experimental ...
FDA grants 1st approval under priority voucher program to Augmentin XR, expediting review and supporting U.S. antibiotic supply chain resilience.
Lawmakers raise concerns over FDA drug voucher program citing safety risks, transparency issues, and legal questions in a Nov. 20 letter to agency leaders.
Companies can ask the FDA to waive premarket authorization and investigational device requirements while they collect ...
U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative announced Tuesday. Food ...
On September 29, 2025, the U.S. Food and Drug Administration (FDA) announced the expansion of its Early Alert program to include all medical devices. This expansion builds on a pilot program that ...
On June 17, 2025, U.S. Food and Drug Administration (FDA) Commissioner Marty Makary announced that the agency is creating a new pilot program called the Commissioner’s National Priority Voucher (CNPV) ...
Saol Therapeutics received a complete response letter for its pyruvate dehydrogenase complex deficiency treatment a week ...
FILE - The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, Tuesday, April 22, 2025. (AP Photo/Jose Luis Magana, File) WASHINGTON (AP) — The Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results